GSK Chief Emma Walmsley to Exit After Eight Years at the Helm
Emma Walmsley, the Chief Executive of GlaxoSmithKline (GSK), is stepping down after eight years of leading one of the world’s largest pharmaceutical companies. Her departure marks the end of a transformative era for the British drugmaker, which faced both breakthroughs and challenges under her leadership.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
